Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
...
Health Technology » Pharmaceuticals Other
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| AMRN | Amarin Corporation Plc Sponsored ADR | 4.81% | 16.12 | 2.0% | $220.21m | |
| SHPG | Shire PLC Sponsored ADR | -0.43% | 180.08 | 0.4% | $214.20m | |
| PRGO | Perrigo Co. Plc | -2.94% | 63.47 | 6.8% | $106.37m | |
| JAZZ | Jazz Pharmaceuticals Plc | -5.91% | 141.79 | 2.2% | $102.24m | |
| ENDP | Endo International Plc | -4.51% | 12.91 | 8.9% | $68.26m | |
| GWPH | GW Pharmaceuticals PLC Sponsored ADR | -2.22% | 129.25 | 6.3% | $64.77m | |
| MNK | Mallinckrodt Plc | -0.52% | 30.91 | 21.1% | $56.81m | |
| SAGE | SAGE Therapeutics, Inc. | -0.90% | 108.05 | 9.6% | $54.08m | |
| ICPT | Intercept Pharmaceuticals, Inc. | -4.15% | 96.53 | 18.7% | $48.16m | |
| HZNP | Horizon Pharma plc | -2.79% | 21.24 | 7.4% | $47.64m | |
| UTHR | United Therapeutics Corporation | -1.55% | 110.97 | 14.4% | $43.54m | |
| CTLT | Catalent Inc | -0.84% | 37.90 | 2.4% | $38.09m | |
| PTLA | Portola Pharmaceuticals, Inc. | -4.48% | 19.18 | 7.7% | $34.63m | |
| ICLR | ICON Plc | -1.62% | 135.76 | 4.1% | $33.24m | |
| AERI | Aerie Pharmaceuticals, Inc. | -4.43% | 41.40 | 6.9% | $28.35m |
Company Profile
SCYNEXIS, Inc. engages in the development and commercialization of novel anti-infectives, which addresses the significant unmet therapeutic needs. It develops a novel oral and intravenous drug for several fungal infections, including serious and life-threatening invasive fungal infections. The company was founded by Scot Kevin Huber, Terry Eugene Marquardt, Pierre Bernard Jacques Monnet, Russell J. Outcalt, and Yves Joseph Ribeill on November 4, 1999 and is headquartered in Jersey City, NJ.